PRESS RELEASE | JW Therapeutics

News Release 07 December, 2020

JW Therapeutics Presents Data from Pivotal Trial of Relma-cel at the 62nd ASH Annual Meeting

News Release 03 November, 2020

Leading Cell Therapy Company JW Therapeutics Lists on Main Board of HKEX

News Release 10 August, 2020

JW Therapeutics and Lyell Immunopharma Announce Collaboration to Advance Solid Tumor Treatment in China

News Release 20 July, 2020

JW Acquires Syracuse Biopharma

News Release 09 June, 2020

JW Therapeutics Completes $ 100 Million Series B Financing

News Release 12 December, 2018

JW Therapeutics announced the grand opening of R&D center in Zhangjiang Science City of Pudong New Area, Shanghai

News Release 10 August, 2018

JW Therapeutics to Build Its First Commercial CAR-T Cell Manufacturing Plant in Suzhou, China

News Release 08 March, 2018

JW Therapeutics Closes $ 90 Million Series A Financing